BioLife Solutions Ownership | Who Owns BioLife Solutions?


OverviewForecastRevenueFinancialsChartTranscripts

BioLife Solutions Ownership Summary


BioLife Solutions is owned by 102.82% institutional investors, 2.37% insiders. T. rowe price investment management is the largest institutional shareholder, holding 13.93% of BLFS shares. T. Rowe Price Small-Cap Stock is the top mutual fund, with 5.11% of its assets in BioLife Solutions shares.

BLFS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioLife Solutions102.82%2.37%-5.19%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryMedical Instruments & Supplies Stocks59.00%13.58%27.42%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
T. rowe price investment management6.75M13.93%$190.65M
Blackrock funding, inc. /de6.38M13.16%$180.05M
Blackrock5.49M12.08%$117.61M
Casdin capital4.66M9.61%$131.46M
Vanguard group3.09M6.44%$74.65M
Invesco2.24M4.62%$63.27M
Vanguard capital management1.96M4.05%$55.47M
State street1.66M3.42%$46.77M
Geode capital management1.09M2.24%$30.70M
Massachusetts financial services co /ma/1.08M2.23%$30.48M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Casdin capital4.66M6.58%$131.46M
Gagnon advisors274.22K5.12%$7.74M
Roubaix capital309.62K3.13%$8.74M
Gagnon securities535.91K2.98%$15.13M
Summit creek advisors180.54K1.74%$5.10M
Next century growth investors558.83K0.84%$15.78M
Cramer rosenthal mcglynn575.79K0.82%$16.26M
Penbrook management39.70K0.72%$1.12M
Granahan investment management521.43K0.52%$14.73M
Uniplan investment counsel188.33K0.50%$5.32M

Top Buyers

HolderShares% AssetsChange
Millennium management625.66K0.01%625.66K
Ubs group832.14K0.00%566.16K
Sixth street partners management company402.90K0.00%402.90K
Roubaix capital309.62K3.13%309.62K
Blackrock funding, inc. /de6.38M0.00%273.78K

Top Sellers

HolderShares% AssetsChange
Casdin capital4.66M6.58%-1.30M
William blair investment management---946.62K
Ameriprise financial66.81K0.00%-834.33K
Fmr993.11K0.00%-477.15K
Rmb capital management---426.01K

New Positions

HolderShares% AssetsChangeValue
Millennium management625.66K0.01%625.66K$17.67M
Sixth street partners management company402.90K0.00%402.90K$11.38M
Roubaix capital309.62K3.13%309.62K$8.74M
Diamond hill capital management153.89K0.03%153.89K$4.35M
Raymond james & associates134.19K0.00%134.19K$2.88M

Sold Out

HolderChange
Larson financial group-4.00
Mendota financial group-4.00
Massmutual trust co fsb/adv-5.00
Rossby financial, lcc-8.00
Capital performance advisors llp-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202621917.11%49,824,599-0.12%1020.94%13933.65%54-
Mar 31, 202696-48.11%10,825,656-77.88%220.22%47-44.05%28-61.64%
Dec 31, 2025137-28.27%24,239,360-49.80%500.50%60-38.78%51-16.39%
Sep 30, 2025183-1.61%48,180,912-0.93%1000.97%95-13.64%5820.83%
Jun 30, 2025190-1.04%49,819,2833.44%1041.00%11230.23%49-22.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
T. Rowe Price Small-Cap Stock2.50M5.11%-65.25K
T. Rowe Price US Small-Cap Core Equity2.50M5.11%-67.08K
iShares Core S&P Small-Cap ETF2.41M4.93%-6.72K
Vanguard Total Stock Mkt Idx Inv1.46M2.99%25.80K
Vanguard Morn Total Stk Mkt Idx Investor1.46M2.99%25.80K
Vanguard US Total Market Shares ETF1.38M2.91%-
T. Rowe Price Instl Small-Cap Stock1.36M2.79%-24.38K
T. Rowe Price U.S. SC Core Eq Tr-D1.19M2.43%-30.18K
iShares Russell 2000 ETF1.07M2.19%-19.01K
Alger Small Cap Focus I1.02M2.09%-

Recent Insider Transactions


DateNameRoleActivityValue
May 19, 2026Casdin Partners Master Fund, L.P.-Sell$6.79M
May 21, 2026Casdin Partners Master Fund, L.P.-Sell$15.40M
May 20, 2026Casdin Partners Master Fund, L.P.-Sell$5.92M
Mar 23, 2026Foster Karen A. Chief Quality and OperationsSell$49.40K
Mar 09, 2026Foster Karen A. Chief Quality and OperationsSell$10.00K

Insider Transactions Trends


DateBuySell
2026 Q2-3
2026 Q1-14
2025 Q4-32
2025 Q3-22
2025 Q2-24

BLFS Ownership FAQ


Who Owns BioLife Solutions?

BioLife Solutions shareholders are primarily institutional investors at 102.82%, followed by 2.37% insiders and -5.19% retail investors. The average institutional ownership in BioLife Solutions's industry, Medical Instruments & Supplies Stocks, is 59.00%, which BioLife Solutions exceeds.

Who owns the most shares of BioLife Solutions?

BioLife Solutions’s largest shareholders are T. rowe price investment management (6.75M shares, 13.93%), Blackrock funding, inc. /de (6.38M shares, 13.16%), and Blackrock (5.49M shares, 12.08%). Together, they hold 39.17% of BioLife Solutions’s total shares outstanding.

Does Blackrock own BioLife Solutions?

Yes, BlackRock owns 12.08% of BioLife Solutions, totaling 5.49M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 117.61M$. In the last quarter, BlackRock increased its holdings by 25.13K shares, a 0.46% change.

Who is BioLife Solutions’s biggest shareholder by percentage of total assets invested?

Casdin capital is BioLife Solutions’s biggest shareholder by percentage of total assets invested, with 6.58% of its assets in 4.66M BioLife Solutions shares, valued at 131.46M$.

Who is the top mutual fund holder of BioLife Solutions shares?

T. Rowe Price Small-Cap Stock is the top mutual fund holder of BioLife Solutions shares, with 5.11% of its total shares outstanding invested in 2.5M BioLife Solutions shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools